Hemophagocytic lymphohistiocytosis · 2 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
DEP Variant #01 | — | R 16 837 | 49d | — | — | ~1 | ~R 16 837 indirect | — |
Emapalumab and Dexamethasone Variant #01 Partial | — | R 87 | — | — | — | ~1 | ~R 87 indirect | — |
2 of 2 regimens shown